Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

LCTX is expected to report earnings to rise 33.33% to -3 cents per share on November 14

Lineage Cell Therapeutics LCTX Stock Earnings Reports

Q3'24

Est.

$-0.04

Q2'24

Beat

by $0.02

Q1'24

Est.

$-0.04

Q4'23

Beat

by $0.01

Q3'23

Beat

by $0.01

The last earnings report on August 08 showed earnings per share of -2 cents, beating the estimate of -4 cents. With 431.94K shares outstanding, the current market capitalization sits at 172.41M.

View a ticker or compare two or three

Compare

LCTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LCTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2173 Salk Avenue

Phone

+1 442 287-8990

Employees

Web

https://www.lineagecell.com